Notice is hereby given that the Office of Research Integrity (ORI) has made a final finding of scientific misconduct in the following case: Fugang Li, Ph.D., University of Oklahoma Health Sciences Center: Based upon a report from the University of Oklahoma, information obtained by the Office of Research Integrity (ORI) during its oversight review, and Dr. Li\'s own admission, ORI found that Dr. Li, a former postdoctoral fellow in the Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, engaged in scientific misconduct by fabricating and falsifying data in conducting and reporting research supported by a grant from the National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH). Specifically, Dr. Li fabricated and falsified data in a study involving the characterization of glycoprotein binding to P-selectin on the surface of human leukocytes. The questioned data were included in a manuscript that was withdrawn prior to publication. Dr. Li has accepted the ORI finding and has entered into a Voluntary Exclusion Agreement with ORI in which he has voluntarily agreed to exclude himself, for the three (3) year period beginning June 3, 1997, from: (1) Any contracting or subcontracting with any agency of the United States Government and from eligibility for, or involvement in, nonprocurement transactions (e.g., grants and cooperative agreements) of the United States Government as defined in 45 CFR Part 76 (debarment Regulations); and (2) Serving in any advisory capacity to the Public Health Service (PHS), including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant. No scientific publications were required to be corrected as part of this Agreement.
